TWI799680B - 製備gip/glp1雙重促效劑之方法 - Google Patents
製備gip/glp1雙重促效劑之方法 Download PDFInfo
- Publication number
- TWI799680B TWI799680B TW109102657A TW109102657A TWI799680B TW I799680 B TWI799680 B TW I799680B TW 109102657 A TW109102657 A TW 109102657A TW 109102657 A TW109102657 A TW 109102657A TW I799680 B TWI799680 B TW I799680B
- Authority
- TW
- Taiwan
- Prior art keywords
- gip
- preparing
- dual agonist
- glp1 dual
- glp1
- Prior art date
Links
- 101100337060 Caenorhabditis elegans glp-1 gene Proteins 0.000 title 1
- 229940125542 dual agonist Drugs 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/645—Secretins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C7/00—Purification; Separation; Use of additives
- C07C7/04—Purification; Separation; Use of additives by distillation
- C07C7/05—Purification; Separation; Use of additives by distillation with the aid of auxiliary compounds
- C07C7/06—Purification; Separation; Use of additives by distillation with the aid of auxiliary compounds by azeotropic distillation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/605—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/47—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Water Supply & Treatment (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Epoxy Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962797963P | 2019-01-29 | 2019-01-29 | |
US62/797,963 | 2019-01-29 | ||
US201962815053P | 2019-03-07 | 2019-03-07 | |
US62/815,053 | 2019-03-07 | ||
US201962818342P | 2019-03-14 | 2019-03-14 | |
US62/818,342 | 2019-03-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
TW202043260A TW202043260A (zh) | 2020-12-01 |
TWI799680B true TWI799680B (zh) | 2023-04-21 |
Family
ID=69724140
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW109102657A TWI799680B (zh) | 2019-01-29 | 2020-01-22 | 製備gip/glp1雙重促效劑之方法 |
Country Status (18)
Country | Link |
---|---|
US (2) | US20220135639A1 (zh) |
EP (1) | EP3917950A1 (zh) |
JP (2) | JP7315683B2 (zh) |
KR (1) | KR20210110349A (zh) |
CN (1) | CN113330024A (zh) |
AU (4) | AU2020216922A1 (zh) |
BR (1) | BR112021012368A2 (zh) |
CA (2) | CA3224820A1 (zh) |
CL (2) | CL2021001905A1 (zh) |
CO (1) | CO2021009662A2 (zh) |
EC (1) | ECSP21056124A (zh) |
IL (1) | IL284446A (zh) |
MA (1) | MA54862A (zh) |
MX (1) | MX2021008965A (zh) |
PE (1) | PE20211992A1 (zh) |
SG (1) | SG11202107123TA (zh) |
TW (1) | TWI799680B (zh) |
WO (1) | WO2020159949A1 (zh) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110642935A (zh) * | 2019-09-25 | 2020-01-03 | 成都奥达生物科技有限公司 | 一种替瑞帕肽类似物 |
EP4257597A1 (en) * | 2020-12-02 | 2023-10-11 | Dongbao Purple Star (Hangzhou) Biopharmaceutical Co., Ltd. | Lactam-modified polypeptide compounds |
MX2023008330A (es) * | 2021-01-20 | 2024-01-18 | Viking Therapeutics Inc | Agonistas del receptor dual gip/glp-1 de molécula pequeña, composiciones farmacéuticas y preparación de las mismas para usarse en el tratamiento de trastornos metabólicos y hepáticos. |
BR112023019389A2 (pt) * | 2021-03-25 | 2023-11-28 | Brightgene Bio Medical Tech Co Ltd | Compostos, agonista de receptor duplo de gip e glp-1, composição farmacêutica compreendendo os mesmos, uso dos mesmos e método para prevenir e/ou tratar doenças associadas a distúrbios metabólicos |
TWI827077B (zh) * | 2021-05-28 | 2023-12-21 | 大陸商廣東眾生睿創生物科技有限公司 | 多肽的製備及其應用 |
WO2023089594A1 (en) | 2021-11-22 | 2023-05-25 | Sun Pharmaceutical Industries Limited | Process for the preparation of tirzepatide or pharmaceutically acceptable salt thereof |
TW202404996A (zh) | 2022-04-04 | 2024-02-01 | 美商美國禮來大藥廠 | 製備glp-1/升糖素雙重促效劑之方法 |
CN116023444B (zh) * | 2022-08-12 | 2023-08-01 | 重庆宸安生物制药有限公司 | 一种gip和glp-1双受体激动剂多肽化合物及其应用 |
WO2024077149A2 (en) * | 2022-10-05 | 2024-04-11 | Eli Lilly And Company | Peptides for incretin synthesis |
WO2024112617A2 (en) | 2022-11-21 | 2024-05-30 | Eli Lilly And Company | Process for preparing a gip/glp1 dual agonist |
WO2024134676A1 (en) * | 2022-12-19 | 2024-06-27 | Dr. Reddy’S Laboratories Limited | Process for the preparation of tirzepatide |
WO2024133236A2 (en) * | 2022-12-19 | 2024-06-27 | Forschungsverbund Berlin E.V. | Peptide conjugates for labelling endogenous gipr and glp-1r |
WO2024136573A1 (ko) * | 2022-12-23 | 2024-06-27 | 한미약품 주식회사 | 신규한 glp-1, gip, 및 글루카곤 수용체 모두에 활성을 갖는 삼중 활성체 및 이를 포함하는 비만의 예방 또는 치료용 약학적 조성물 |
WO2024145638A2 (en) * | 2022-12-29 | 2024-07-04 | Eli Lilly And Company | Processes and intermediates for preparing tirzepatide |
WO2024184352A1 (en) | 2023-03-06 | 2024-09-12 | Ascendis Pharma A/S | Drug compounds comprising albumin-binding moieties |
CN116731154A (zh) * | 2023-08-14 | 2023-09-12 | 苏州金顶生物有限公司 | 一种全液相法制备替西帕肽的方法 |
CN117736273B (zh) * | 2023-12-08 | 2024-05-07 | 广东省卓肽医药有限公司 | 一种替尔泊肽的纯化方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1076066A1 (en) * | 1999-07-12 | 2001-02-14 | Zealand Pharmaceuticals A/S | Peptides for lowering blood glucose levels |
JP2012525348A (ja) | 2009-05-01 | 2012-10-22 | エフ.ホフマン−ラ ロシュ アーゲー | 固相及び溶液相の組み合わせ技術を用いたインスリン分泌促進ペプチド合成 |
JOP20200119A1 (ar) | 2015-01-09 | 2017-06-16 | Lilly Co Eli | مركبات مساعد مشترك من gip وglp-1 |
CN106928086B (zh) * | 2015-12-31 | 2019-05-31 | 深圳翰宇药业股份有限公司 | 一种长链化合物的制备方法 |
-
2020
- 2020-01-22 TW TW109102657A patent/TWI799680B/zh active
- 2020-01-28 SG SG11202107123TA patent/SG11202107123TA/en unknown
- 2020-01-28 MX MX2021008965A patent/MX2021008965A/es unknown
- 2020-01-28 KR KR1020217024133A patent/KR20210110349A/ko not_active Application Discontinuation
- 2020-01-28 CA CA3224820A patent/CA3224820A1/en active Pending
- 2020-01-28 US US17/310,247 patent/US20220135639A1/en active Pending
- 2020-01-28 MA MA054862A patent/MA54862A/fr unknown
- 2020-01-28 EP EP20707971.6A patent/EP3917950A1/en active Pending
- 2020-01-28 PE PE2021001218A patent/PE20211992A1/es unknown
- 2020-01-28 WO PCT/US2020/015353 patent/WO2020159949A1/en active Application Filing
- 2020-01-28 JP JP2021542153A patent/JP7315683B2/ja active Active
- 2020-01-28 CA CA3128023A patent/CA3128023A1/en active Pending
- 2020-01-28 AU AU2020216922A patent/AU2020216922A1/en not_active Abandoned
- 2020-01-28 CN CN202080011536.7A patent/CN113330024A/zh active Pending
- 2020-01-28 BR BR112021012368-7A patent/BR112021012368A2/pt unknown
-
2021
- 2021-06-28 IL IL284446A patent/IL284446A/en unknown
- 2021-07-19 CL CL2021001905A patent/CL2021001905A1/es unknown
- 2021-07-23 CO CONC2021/0009662A patent/CO2021009662A2/es unknown
- 2021-07-29 EC ECSENADI202156124A patent/ECSP21056124A/es unknown
-
2023
- 2023-02-16 JP JP2023022752A patent/JP2023078130A/ja active Pending
- 2023-05-15 AU AU2023203001A patent/AU2023203001B2/en active Active
- 2023-12-11 CL CL2023003709A patent/CL2023003709A1/es unknown
-
2024
- 2024-02-16 AU AU2024201004A patent/AU2024201004A1/en active Pending
- 2024-06-24 US US18/751,768 patent/US20240368240A1/en active Pending
- 2024-08-16 AU AU2024205812A patent/AU2024205812A1/en active Pending
Non-Patent Citations (1)
Title |
---|
期刊 Mroz P.A., et al., "Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonism" Molecular metabolism, 20 2019 (Available online: 5 December 2018), page 51–62. |
Also Published As
Publication number | Publication date |
---|---|
JP2022517834A (ja) | 2022-03-10 |
AU2020216922A1 (en) | 2021-07-15 |
CA3128023A1 (en) | 2020-08-06 |
MA54862A (fr) | 2022-05-04 |
AU2024201004A1 (en) | 2024-03-07 |
IL284446A (en) | 2021-08-31 |
CN113330024A (zh) | 2021-08-31 |
CL2023003709A1 (es) | 2024-06-07 |
US20240368240A1 (en) | 2024-11-07 |
SG11202107123TA (en) | 2021-08-30 |
AU2023203001A1 (en) | 2023-06-08 |
TW202043260A (zh) | 2020-12-01 |
JP7315683B2 (ja) | 2023-07-26 |
MX2021008965A (es) | 2021-08-24 |
CA3224820A1 (en) | 2020-08-06 |
US20220135639A1 (en) | 2022-05-05 |
KR20210110349A (ko) | 2021-09-07 |
AU2024205812A1 (en) | 2024-09-05 |
BR112021012368A2 (pt) | 2021-09-14 |
CL2021001905A1 (es) | 2022-03-11 |
WO2020159949A1 (en) | 2020-08-06 |
AU2023203001B2 (en) | 2024-03-28 |
JP2023078130A (ja) | 2023-06-06 |
PE20211992A1 (es) | 2021-10-18 |
CO2021009662A2 (es) | 2021-08-09 |
ECSP21056124A (es) | 2021-08-31 |
EP3917950A1 (en) | 2021-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI799680B (zh) | 製備gip/glp1雙重促效劑之方法 | |
EP4029849A4 (en) | METHOD FOR PRODUCING M-TRIFLUORMETHYLPHENOL | |
GB2589908B (en) | A method for preparing a geoolymer composition | |
EP4073013A4 (en) | NEW PROCESS FOR HIGH-PERFORMANCE CEMENT | |
EP3865468A4 (en) | PROCESS FOR MANUFACTURING PERFLUOROALKYNE COMPOUND | |
EP4025717A4 (en) | PROCESS FOR PREPARING ALUMINA | |
EP3953299A4 (en) | NTP MANUFACTURING PROCESSES | |
EP4086277A4 (en) | LONG-ACTING GLP-1 COMPOUND | |
EP3825448A4 (en) | PROCESS FOR PREPARING A VPA FIBER | |
EP3966270A4 (en) | PROCESS FOR THE PRODUCTION OF POLYORGANOSILOXANES | |
EP3696045A4 (en) | LOCKING MECHANISM FOR POINT MACHINE | |
EP4082997A4 (en) | Alkene manufacturing method | |
EP4032297A4 (en) | METHODS FOR CONSTRUCTING A LIST OF MERGER CANDIDATES | |
EP3864092A4 (en) | PROCESS FOR PREPARING A RESIN | |
EP3820878A4 (en) | METHOD FOR PREPARING SULFONAMIDE COMPOUNDS | |
EP3960916A4 (en) | METHOD FOR PREPARING A PHAGE LIBRARY | |
EP3914670A4 (en) | PRODUCTION OPTIMIZATION PROCESSES FOR ETHYLENE FURNACES | |
EP3841074A4 (en) | MACHINE FOR MAKING COMPOSITES | |
EP3858816A4 (en) | NOVEL PROCESS FOR THE PRODUCTION OF (-)-CIBENZOLINE SUCCINATE | |
HUE064895T2 (hu) | Eljárás palbociklib elõállítására | |
EP3774298A4 (en) | SELECTING A DEPOWING PROCESS FOR 3D PRINTING | |
SG11202009447XA (en) | Process for transferring a layer | |
EP4031585C0 (en) | METHOD FOR PREPARING A NANOSPONGE | |
IL286006A (en) | Process for preparing 4-amino-5-methylpyridone | |
EP3937978A4 (en) | IMMUNOSUPPRESSION METHOD |